Alpha Cognition Inc. Common Stock
Alpha Cognition Inc. Common Stock（ACOG）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · ACOG · 截至 2025年9月30日
股东结构概览
28
机构持有人数
▲ 2 vs Q2
$36.74M
机构持仓总市值
▼ $16.62M vs Q2
15.53M
总流通股
freeFloat 78.02%
5.64M
13F 申报持股数
▼ 75,918 vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
ACOG 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
SOLAS CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 1.28M | 8.00% | 8.00% | $8.35B | Nov 14, 2025 | ▲ 6.2K |
AWM INVESTMENT COMPANY, INC. biological products, (no diagnostic substances) | 1.10M | 6.84% | 6.84% | $7.13B | Nov 13, 2025 | — held |
IKARIAN CAPITAL, LLC biological products, (no diagnostic substances) | 946.3K | 5.91% | 5.91% | $6.16B | Nov 14, 2025 | ▲ 28.4K |
CABLE CAR CAPITAL LLC biological products, (no diagnostic substances) | 869.0K | 5.42% | 5.42% | $5.66B | Nov 14, 2025 | — held |
SPHERA FUNDS MANAGEMENT LTD. biological products, (no diagnostic substances) | 338.8K | 2.11% | 2.11% | $2.21B | Nov 14, 2025 | ▼ 37.9K |
BOOTHBAY FUND MANAGEMENT, LLC biological products, (no diagnostic substances) | 291.9K | 1.82% | 1.82% | $1.90B | Nov 14, 2025 | ▲ 28.4K |
ARISTIDES CAPITAL LLC biological products, (no diagnostic substances) | 165.5K | 1.03% | 1.03% | $1.08B | Nov 13, 2025 | — held |
CORSAIR CAPITAL MANAGEMENT, L.P. biological products, (no diagnostic substances) | 134.9K | 84.20% | 84.20% | $878.19M | Apr 21, 2026 | — held |
OPALEYE MANAGEMENT INC. biological products, (no diagnostic substances) | 115.1K | 71.87% | 71.87% | $749.57M | Nov 14, 2025 | NEW |
MARSHALL WACE, LLP biological products, (no diagnostic substances) | 72.2K | 45.07% | 45.07% | $470.10M | Nov 13, 2025 | ▲ 7.9K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
8
增持
+78.6K 股7
新建仓
首次建仓4
减持
−84.9K 股5
清仓
完全退出净股数变化（前50家）
6.2K
+78.6K / −84.9K
净新增持仓人
+6
新建 7 个 / 退出 5 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
ACOG 内幕交易记录
数据来源：SEC Form 4
近期内部人员净买入。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
10
买入笔数
0
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Opaleye Management Inc. 10 percent owner | May 29, 2026 | Purchase | 70,577 | $5.90 | $416.4K | 2.60M | Form 4 ↗ |
Opaleye Management Inc. 10 percent owner | May 28, 2026 | Purchase | 2,000 | $5.83 | $11.7K | 2.53M | Form 4 ↗ |
Opaleye Management Inc. 10 percent owner | May 27, 2026 | Purchase | 1,161 | $5.73 | $6.7K | 2.53M | Form 4 ↗ |
Opaleye Management Inc. 10 percent owner | May 21, 2026 | Purchase | 15,945 | $5.70 | $90.9K | 2.53M | Form 4 ↗ |
Opaleye Management Inc. 10 percent owner | May 20, 2026 | Purchase | 8,431 | $5.89 | $49.7K | 2.51M | Form 4 ↗ |
D'Angelo Lauren Chief Operating Officer | May 19, 2026 | Purchase | 3,500 | $5.76 | $20.2K | 140.7K | Form 4 ↗ |
Opaleye Management Inc. 10 percent owner | May 18, 2026 | Purchase | 17,395 | $5.69 | $99.0K | 2.51M | Form 4 ↗ |
Opaleye Management Inc. 10 percent owner | May 15, 2026 | Purchase | 16,648 | $5.83 | $97.0K | 2.49M | Form 4 ↗ |
Sensenig Bethany director | Apr 16, 2026 | Award | 6,991 | $6.65 | $46.5K | 7.0K | Form 4 ↗ |
Sensenig Bethany director | Apr 16, 2026 | Award | 5,489 | — | — | 5.5K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Alpha Cognition Inc. Common Stock（ACOG）主要由机构投资者持有，机构持股比例约为 36.3%。公司内部人员持股约 21.98%，散户及公众持股约占剩余的 41.68%。
Alpha Cognition Inc. Common Stock 最大机构股东为 SOLAS CAPITAL MANAGEMENT, LLC，截至 September 30, 2025 持有约 1.28 million 股，占总流通股的 8.00%。
目前共有 28 家机构持有 ACOG 股票，合计持仓市值约 $36,736,714，数据来源为最新 SEC 13F 申报。
常见问题
ACOG ownershipAlpha Cognition Inc. Common Stock（ACOG）主要由机构投资者持有，机构持股约 36.3%。最大股东为 SOLAS CAPITAL MANAGEMENT, LLC，持股比例 8.00%。内部人员持股约 21.98%。数据来源 SEC Form 13F，截至 September 30, 2025。